BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 34491710)

  • 21. Predictive Validity of the Beers and Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP) Criteria to Detect Adverse Drug Events, Hospitalizations, and Emergency Department Visits in the United States.
    Brown JD; Hutchison LC; Li C; Painter JT; Martin BC
    J Am Geriatr Soc; 2016 Jan; 64(1):22-30. PubMed ID: 26782849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geriatric Polypharmacy: Two Physicians' Personal Perspectives.
    Chen Z; Buonanno A
    Clin Geriatr Med; 2017 May; 33(2):283-288. PubMed ID: 28364996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polypharmacy in the Emergency Department.
    Nguyen KH; Tolia V; Hart LA
    Clin Geriatr Med; 2022 Nov; 38(4):727-732. PubMed ID: 36210088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing polypharmacy through medication review tools - pros and cons.
    Gavazova E; Staynova R; Grekova-Kafalova D
    Folia Med (Plovdiv); 2024 Apr; 66(2):161-170. PubMed ID: 38690810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tackling potentially inappropriate prescriptions in older adults: development of deprescribing criteria by consensus from experts in Colombia, Argentina, and Spain.
    De Las Salas R; Vaca-González C; Eslava-Schmalbach J; Torres-Espinosa C; Figueras A
    BMC Geriatr; 2023 Oct; 23(1):682. PubMed ID: 37864147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is my older cancer patient on too many medications?
    Turner JP; Shakib S; Bell JS
    J Geriatr Oncol; 2017 Mar; 8(2):77-81. PubMed ID: 27840102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New horizons in deprescribing for older people.
    Woodford HJ; Fisher J
    Age Ageing; 2019 Nov; 48(6):768-775. PubMed ID: 31595290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
    Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
    Trials; 2016 Jan; 17():57. PubMed ID: 26822311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deprescribing of non-antiretroviral therapy in HIV-infected patients.
    Blanco JR; Morillo R; Abril V; Escobar I; Bernal E; Folguera C; Brañas F; Gimeno M; Ibarra O; Iribarren JA; Lázaro A; Mariño A; Martín MT; Martinez E; Ortega L; Olalla J; Robustillo A; Sanchez-Conde M; Rodriguez MA; de la Torre J; Sanchez-Rubio J; Tuset M;
    Eur J Clin Pharmacol; 2020 Mar; 76(3):305-318. PubMed ID: 31865412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deprescribing: A simple method for reducing polypharmacy.
    McGrath K; Hajjar ER; Kumar C; Hwang C; Salzman B
    J Fam Pract; 2017 Jul; 66(7):436-445. PubMed ID: 28700758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inappropriate polypharmacy management versus deprescribing: A review on their relationship.
    Zidan A; Awaisu A
    Basic Clin Pharmacol Toxicol; 2024 Jan; 134(1):6-14. PubMed ID: 37350370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frailty, polypharmacy and deprescribing.
    Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of deprescribing in older adults with dementia: a narrative review.
    Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
    Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
    [No Abstract]   [Full Text] [Related]  

  • 34. Reducing inappropriate polypharmacy: the process of deprescribing.
    Scott IA; Hilmer SN; Reeve E; Potter K; Le Couteur D; Rigby D; Gnjidic D; Del Mar CB; Roughead EE; Page A; Jansen J; Martin JH
    JAMA Intern Med; 2015 May; 175(5):827-34. PubMed ID: 25798731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.
    Reeve E; Moriarty F; Nahas R; Turner JP; Kouladjian O'Donnell L; Hilmer SN
    Expert Opin Drug Saf; 2018 Jan; 17(1):39-49. PubMed ID: 29072544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial.
    Adam L; Moutzouri E; Baumgartner C; Loewe AL; Feller M; M'Rabet-Bensalah K; Schwab N; Hossmann S; Schneider C; Jegerlehner S; Floriani C; Limacher A; Jungo KT; Huibers CJA; Streit S; Schwenkglenks M; Spruit M; Van Dorland A; Donzé J; Kearney PM; Jüni P; Aujesky D; Jansen P; Boland B; Dalleur O; Byrne S; Knol W; Spinewine A; O'Mahony D; Trelle S; Rodondi N
    BMJ Open; 2019 Jun; 9(6):e026769. PubMed ID: 31164366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicians need to take the lead in deprescribing.
    Scott IA; Le Couteur DG
    Intern Med J; 2015 Mar; 45(3):352-6. PubMed ID: 25735580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.
    Palagyi A; Keay L; Harper J; Potter J; Lindley RI
    BMC Geriatr; 2016 Jan; 16():15. PubMed ID: 26767619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deprescribing to Reduce Medication Use: Will This Help Your Patient?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2016 Nov; 54(11):21-24. PubMed ID: 27805712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interventions to improve the appropriate use of polypharmacy for older people.
    Patterson SM; Hughes C; Kerse N; Cardwell CR; Bradley MC
    Cochrane Database Syst Rev; 2012 May; (5):CD008165. PubMed ID: 22592727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.